Dysbiosis impairs incretin signaling, reducing the effectiveness of GLP-1 therapies
Weigh and measure food until you have a good idea of what a portion should look like
Doctors respond differently to patients who frame the discussion in clinical terms versus those who simply say they want to lose weight
SeekPeptides members connect with practitioners experienced in peptide-based approaches to inflammatory conditions
In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
MASLD contributes to HFpEF through several interconnected mechanisms